Safety Alerts and Recalls

Safety Alerts & Recalls

FDA: Testosterone Replacement Tx Review Prompts New Warnings, Updated Labeling

The Food and Drug Administration (FDA) announced that prescription testosterone product labels must be changed to clarify the approved use of these medications and information on the possible increased risk of heart attacks and strokes in patients taking testosterone must also be added.

Withdrawn Drug Found in Weight Loss Supplement

The Food and Drug Administration (FDA) has issued a warning to not buy or use Elimulating Weight & Toxin Keeping Beauty, a product promoted for weight loss.

Even More Tainted Sex Enhancement Pills Discovered in International Shipments

The Food and Drug Administration (FDA) is warning consumers to not use or buy SEx Men, Super Hard, Santi Scalper, Vigra, Plant Vigra, Vigour 300, MME MAXMAN, Hard Wang, FX3000 after they were found to contain hidden drug ingredients.

FDA Uncovers Six Tainted Sex Enhancement Pills

The Food and Drug Administration (FDA) has warned against the use of Libigrow XXX Treme, Night Man, Black King Kong, 72HP, Tibet Babao, and Germany Niubian supplements promoted for sexual enhancement.

FDA Issues Warning on Four Tainted Weight Loss Supplements

The FDA has warned consumers to not buy or use the weight loss supplements Oxy ELITE Pro Super Thermogenic, Nine Slim, Seven Slim, and Botanical Slimming (Red) after they were found to contain undeclared drug ingredients.

Diabetes Pen Devices to Display Additional Warning Labels

The Food and Drug Administration (FDA) announced that multi-dose diabetes pen devices intended for single patient use only are now required to add additional label warnings prohibiting the sharing of these injectable medicines.

Recall of Two IV Antibiotics Announced

Heritage Pharmaceuticals announced a voluntary nationwide recall of 10 lots of Colistimethate for Injection 150mg, and three lots of Rifampin for Injection 600mg.

FTC Cracks Down on Melanoma Detection Apps

The Federal Trade Commission (FTC) has announced that the agency is actively challenging several marketers of mobile apps promoted to detect symptoms of melanoma (even in its early stages) due to deceptive claims.

IV Anesthesia Vials Recalled Due to Sterility Issues

Sagent announced its voluntary nationwide recall of two lots of Atracurium Besylate Injection 50mg/5mL single-dose vials and four lots of Atracurium Besylate Injection 100mg/10mL multi-dose vials.

Particulate Found in Vials Prompts NSAID Recall

Hospira announced a voluntary recall of Ketorolac Tromethamine Injection due to potential particulate following a customer's report of visible, floating particulate seen in the glass fliptop vials.